Vitková Zuzana, Dodek Martin, Pavlovičová Jarmila, Vitko Anton
Faculty of Electrical Engineering and Information Technology, Institute of Robotics and Cybernetics, Slovak University of Technology in Bratislava, Ilkovičova 3, 812 19 Bratislava, Slovakia.
Pharmaceutics. 2022 Apr 14;14(4):861. doi: 10.3390/pharmaceutics14040861.
In the first part of this paper, the problem of using an uncertain pharmacokinetic model is resolved to determine drug concentrations in rats after the oral administration of drug suspensions with and without added tenside. To this end, a generalized pharmacokinetic model determining the guaranteed limits of drug concentrations was designed. Based on this, the design of the so-called state-bounding observer is described in the second part. Rather than being driven by the output of the pharmacokinetic model, the observer can be driven exclusively by a concentration collected from a suitable part of the body and predict the possible risk of the drug concentration not remaining within the therapeutic range for a sufficiently long time. Specifically, the observer determines the upper and lower limits of the concentrations in all the compartments, especially those that are inaccessible for the collection of samples. The proposed approaches are demonstrated by examples.
在本文的第一部分,解决了使用不确定药代动力学模型来确定大鼠口服添加和未添加表面活性剂的药物混悬液后的药物浓度问题。为此,设计了一个确定药物浓度保证极限的广义药代动力学模型。基于此,第二部分描述了所谓的状态边界观测器的设计。该观测器不是由药代动力学模型的输出驱动,而是仅由从身体合适部位采集的浓度驱动,并预测药物浓度在足够长的时间内未保持在治疗范围内的可能风险。具体而言,观测器确定所有隔室中浓度的上限和下限,特别是那些无法采集样本的隔室。通过实例展示了所提出的方法。